Literature DB >> 9831180

Molecules associated with human Th1 or Th2 cells.

F Annunziato1, G Galli, L Cosmi, P Romagnani, R Manetti, E Maggi, S Romagnani.   

Abstract

In the last few years, some surface molecules which preferentially associate with human Th1 or Th2 cells have been described. Th1-related molecules include CD26, membrane IFN-gamma, LAG-3, CCR5 and CXCR3, whereas CD62L, CD30, CCR3, CCR4, CCR8, and in a certain way even CXCR4, preferentially associate with human Th2 cells during certain phases of their differentiation/activation process. Although none of these molecules can be considered as a truly selective marker of human Th1 or Th2 cells, their combined detection may help to characterize the pathway of the specific immune response both in vitro and in vivo. Moreover, the understanding of mechanisms responsible for these associations may provide new insights into the functional programs of the specific effector cells, as well as on their regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831180

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  10 in total

Review 1.  Overtraining, excessive exercise, and altered immunity: is this a T helper-1 versus T helper-2 lymphocyte response?

Authors:  Lucille Lakier Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

Review 4.  New insights into the role of cytokines in asthma.

Authors:  J C Renauld
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

5.  Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjogren's syndrome.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Taio Naniwa; Mikae Nakamura; Shigeki Sato; Yuji Ohtsuki; Jiro Fujita; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2004-09-10       Impact factor: 4.064

6.  STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects.

Authors:  Katsuyuki Tomita; Gaetano Caramori; Kazuhiro Ito; Hiroyuki Sano; Sam Lim; Timothy Oates; Borja Cosio; K Fan Chung; Yuji Tohda; Peter J Barnes; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2012-03-09       Impact factor: 4.981

7.  Reconstitution of Peripheral T Cells by Tissue-Derived CCR4+ Central Memory Cells Following HIV-1 Antiretroviral Therapy.

Authors:  Yolanda D Mahnke; Kipper Fletez-Brant; Irini Sereti; Mario Roederer
Journal:  Pathog Immun       Date:  2016

8.  T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.

Authors:  Francisco Javier Gil-Etayo; Patricia Suàrez-Fernández; Oscar Cabrera-Marante; Daniel Arroyo; Sara Garcinuño; Laura Naranjo; Daniel E Pleguezuelo; Luis M Allende; Esther Mancebo; Antonio Lalueza; Raquel Díaz-Simón; Estela Paz-Artal; Antonio Serrano
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

9.  Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.

Authors:  Ludovica F Buttó; Li-Guo Jia; Kristen O Arseneau; Hiroshi Tamagawa; Alex Rodriguez-Palacios; Zhaodong Li; Carlo De Salvo; Theresa T Pizarro; Giorgos Bamias; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

Review 10.  CD26 and Asthma: a Comprehensive Review.

Authors:  Juan J Nieto-Fontarigo; Francisco J González-Barcala; Esther San José; Pilar Arias; Montserrat Nogueira; Francisco J Salgado
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.